(Nasdaq: AMST) Stock Catalyst: Amesite's NurseMagic Secures Record 2,700-Census Home Care Enterprise Customer

Amesite makes the Nasdaq top percentage gainers list on news of a new customer. The stock is trading at 1.7810 +0.9949 (+126.56%) on volume of over 122 Million shares.

Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $1.5 trillion non-acute care segments. Its flagship product, NurseMagic(TM), streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic(TM) is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic(TM) meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. amesite.com

Amesite announced it has secured a new enterprise customer representing an approximately 2,700-patient census, its largest deployment to date and a major milestone in validating its enterprise strategy.

The customer will deploy NurseMagic(TM) AI documentation across its workforce to streamline workflows, integrate their EMR, and integrate with their electronic visit verification (EVV) workflow. The deployment is expected to significantly reduce the administrative burden that currently consumes up to 16 hours per caregiver per week.

This win represents a step-function increase in scale, substantially expanding NurseMagic(TM)'s enterprise census footprint and demonstrating the platform's ability to operate across complex organizations.

Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, "This 2,700-census deployment validates the strength of our architecture. We are supporting multiple roles, layered permissions, EMR and EVV integration, and custom documentation across thousands of patients - without the heavy consulting, technology fees, and custom development that typically drive up pricing from legacy providers. Because NurseMagic(TM) is AI-first, automated, and configurable, we launch new customers quickly, without weeks or months of onboarding. This achievement reflects the successful transition from an assistive tool to core clinical infrastructure in the $1.5T+2-7 non-acute/post-acute market. For investors, it demonstrates that our platform scales into enterprise environments while preserving strong economics, even as we continue to maintain fiscal discipline."

"We executed this deployment with the same financial discipline we have applied across the company over the last several quarters," said Sarah Berman, Principal Finance and Accounting Officer. "By building NurseMagic(TM) as an AI-first, configurable platform, we have been able to automate work that historically required significant human support. That approach has contributed to approximately 18% reduction in operating spend over the last 6 quarters, while supporting a growing base of paying customers. As we scale into larger enterprises, we expect our automation efficiencies to continue to benefit our unit economics and support margin expansion over time."

Full news release

Research tech stocks at Investorideas.com’s free stock directory

https://www.investorideas.com/TSS/stock_list.asp